ACE2 and Sepsis: The final results of this study indicate that patients with confirmed sepsis and circulating ACE2 concentrations ≥ 2.5 ng/mL during the early phase of critical illness have an increased risk of developing AKI within 48 hours of ICU admission and face higher ICU mortality.